An innovative, PhD programme, competitively funded for 3 years, has been established between the University of Cambridge and MedImmune. The programme will provide the opportunity to work at the interface of academia and industry with successful applicants undertaking a significant proportion of their research at both the University of Cambridge and at MedImmune.
The programme aims to promote pre-clinical innovative translational research and to strengthen understanding of disease.
MedImmune, the global biologics unit of AstraZeneca, is committed to developing better medicines that help people live healthier, longer and more satisfying lives. The company is focused on the areas of cardiovascular and metabolic disease, infection, respiratory and inflammatory disease, oncology and neuroscience, with two marketed products and a robust pipeline of promising new product candidates. MedImmune's state-of-the-art Cambridge site is home to around 600 employees, and serves as the company's European hub for research and development.
Please see further information about this PhD Programme and Project Title attached.
Previous applicants need not re-apply
Fixed-term: The funds for this post are available for 3 years in the first instance.
Applicants are encouraged to contact the Cambridge Supervisors informally for further information about the projects.
Professor PJ Lehner and Professor ER Chilvers (email@example.com ), Department of Medicine, University of Cambridge.
Dr D Finch, Respiratory, Inflammation and Autoimmunity, MedImmune Ltd., Cambridge
How to Apply
Please note that this project is open to UK/EU applicants only.
Applications should be made directly to the University application portal http://www.graduate.study.cam.ac.uk/courses/directory/ and include a CV with 3 referees and a 2 page statement of research interest.
The website for further application details: http://cato.medschl.cam.ac.uk/recruitment/graduate-programmes-recruitment/phd-programmes-recruitment/cambridge-medimmune-recruitment/
Please include details of your referees, including email address and phone number, one of which must be your most recent line manager.
The closing date for applications is the 10th May 2017 with interviews yet to be confirmed by the department.
Please quote reference RC11452 on your application and in any correspondence about this vacancy.
The University values diversity and is committed to equality of opportunity.
The University has a responsibility to ensure that all employees are eligible to live and work in the UK.
Ph D Studentship, Anglia Ruskin University, United Kingdom, about 2 months ago
The Peterborough Burns Unit Appeal Fund-Supported Research: Development of novel anti-fibrotic medicines through phenotypic screening to prevent scar formation. Scarring following burn injury and ...